Talk:Fluticasone furoate/vilanterol

Refs not about topic in question
So moved here.

Fluticasone Furoate, an inhaled corticosteroid, has been shown to have a potent pharmacological profile on a respiratory inflammation disease in animal studies. It was described as being safe and effective. Additionally, inhaled corticosteroids have been shown to have a beneficial risk/benefit ratio in patients over multiple studies, with that caveat that chronic use be monitored. They were also shown to have a favorable risk/benefit ratio in the treatment of patients with Chronic Obstructive Pulmonary Disorder (COPD). Similarly, Vilanterol was shown to be a potent, selective ß2 Adrenoceptor agonist with a long duration of action. Long-acting ß2 Adrenoceptor agonists were shown to be safe for use in patients with stable moderate-to-severe COPD in another systematic review.

Doc James (talk · contribs · email) 19:11, 20 November 2016 (UTC)